NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
20 hedge funds and large institutions have $124K invested in InVivo Therapeutics Holdings Corp in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14K | |
| 2 | +$13.6K | |
| 3 | +$9.86K | |
| 4 |
Renaissance Technologies
New York
|
+$980 |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$21 |
Top Sellers
| 1 | -$522K | |
| 2 | -$3.77K | |
| 3 | -$1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$559 |
| 5 |
Morgan Stanley
New York
|
-$33 |